We speculate that TRAF3IP3 and LFNG methylation variations may serve as potential epigenetic biomarkers for COVID-19, and that they play a role in important biological processes like the immune response and antiviral activity [47,48]. Here, TRAF3IP3 is linked to COVID-19.